rs121964894
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 15P and 4B. PM1PM5PP2PP3_ModeratePP5_Very_StrongBS2
The NM_000552.5(VWF):c.2446C>T(p.Arg816Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R816Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VWF | NM_000552.5 | c.2446C>T | p.Arg816Trp | missense_variant | 19/52 | ENST00000261405.10 | |
VWF | XM_047429501.1 | c.2446C>T | p.Arg816Trp | missense_variant | 19/52 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VWF | ENST00000261405.10 | c.2446C>T | p.Arg816Trp | missense_variant | 19/52 | 1 | NM_000552.5 | P1 | |
VWF | ENST00000538635.5 | n.421-42554C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes ? AF: 0.0000394 AC: 6AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251368Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135864
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461776Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727194
GnomAD4 genome ? AF: 0.0000394 AC: 6AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74332
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
not provided, no classification provided | literature only | Academic Unit of Haematology, University of Sheffield | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2023 | Published functional studies demonstrate a damaging effect, including greatly decreased FVIIIB binding (van den Biggelaar et al., 2009; Qin et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also reported as R53W due to the use of alternative nomenclature; This variant is associated with the following publications: (PMID: 34708896, 26210168, 18728373, 1832934, 7847341, 28971901, 26988807, 21534937, 19088379, 31589614, 24351655) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 01, 2023 | - - |
Hereditary von Willebrand disease Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 08, 2019 | The p.Arg816Trp variant in VWF has been reported in 6 homozygous, 4 compound heterozygous, and 2 heterozygous (only 1 allele identified) individuals with von Willebrand disease (VWD) and segregated with disease in at least 2 affected individuals from 1 family (Gaucher 1991, Johansson 2011, Qin 2014, Argyris 2016, Fidalgo 2016, Borras 2017). It has also been identified in 9/35418 Latino chromosomes by gnomAD (http://gnomad.broadinstitute.org). However, this frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In vitro functional studies support an impact on protein function (Qin 2004). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive VWD. ACMG/AMP criteria applied: PM3_VeryStrong, PP1_Moderate, PM2_Supporting, PP3, PS3_Supporting. - |
von Willebrand disease type 2N Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2010 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at